Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Treatment of Active Psoriatic Arthritis
.
Show all posts
Showing posts with label
Treatment of Active Psoriatic Arthritis
.
Show all posts
Monday, February 12, 2018
Pfizer Announces FDA Approval of Xeljanz (tofacitinib) and Xeljanz XR for the Treatment of Active Psoriatic Arthritis
›
In continuation of my update on tofacitinib Pfizer Inc. announced that the United States Food and Drug Administration (FDA) has ap...
›
Home
View web version
